1577P Optimizing the management of PARP inhibitors in clinical practice: Results of a DELPHI French consensus

Autor:	F. Selle, F. Scotté, J-J. Boffa, G. Etienne, A. Angelergues, P. Augereau, D. Berton-Rigaud, P. Dielenseger, M. Fabbro, C. Falandry, P. Follana, L. Gladieff, F. Joly Lobbedez, J.E. Kurtz, C. Matta, M.A. Mouret Reynier, A. Schmitt, C. Marjollet, A. Floquet
Rok vydání:	2022
Předmět:	Oncology Hematology
Zdroj:	Annals of Oncology. 33:S1267
ISSN:	0923-7534
DOI:	10.1016/j.annonc.2022.07.1670
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::81d5b2ec3f920837ef10fab28cf127c2 https://doi.org/10.1016/j.annonc.2022.07.1670 Zobrazit plný text záznamu